Actinomyces neuii subspecies anitratus chronic endophthalmitis after cataract surgery. 2007

J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
Department of Ophthalmology, Hospital Virgen de los Lirios, Alcoy, Spain. jjpsantonja@coma.es

OBJECTIVE To report a case of unusual chronic endophthalmitis by Actinomyces neuii subspecies anitratus. METHODS A 75-year-old man underwent uneventful phacoemulsification with implantation of a foldable posterior chamber intraocular lens in his right eye. Four weeks after surgery, a chronic post-operative endophthalmitis characterized by anterior chamber and vitreous cellular debris developed in this eye. Cultures were positive, and A neuii subspecies anitratus was identified by polymerase chain reaction and subsequent rRNA sequence analysis. Immediate treatment included intravitreal and intensive topical antibiotics along with oral ciprofloxacin. RESULTS The condition improved rapidly, and 6 months after surgery the patient was asymptomatic, the best spectacle-corrected visual acuity was 20/22, and the anterior chamber was quiet. CONCLUSIONS A neuii subspecies anitratus should be considered in the differential diagnosis of chronic endophthalmitis after cataract surgery. Polymerase chain reaction and subsequent RNA typing were useful in detecting the causative organism, and intravitreal antibiotics were successful.

UI MeSH Term Description Entries
D008297 Male Males
D009877 Endophthalmitis Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection. Ophthalmia,Infectious Endophthalmitis,Endophthalmitides,Endophthalmitides, Infectious,Endophthalmitis, Infectious,Infectious Endophthalmitides,Ophthalmias
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000190 Actinomyces A genus of gram-positive, rod-shaped bacteria whose organisms are nonmotile. Filaments that may be present in certain species are either straight or wavy and may have swollen or clubbed heads.
D000196 Actinomycosis Infections with bacteria of the genus ACTINOMYCES. Actinomyces Infections,Infections, Actinomyces,Actinomyces Infection,Actinomycoses,Infection, Actinomyces
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents

Related Publications

J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
December 2004, Journal of cataract and refractive surgery,
J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
June 2002, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
January 2002, American journal of ophthalmology,
J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
January 2017, Retinal cases & brief reports,
J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
January 2012, European journal of ophthalmology,
J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
February 2022, BMC veterinary research,
J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
January 1995, Eye (London, England),
J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
January 1994, International journal of systematic bacteriology,
J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
January 2000, Archivos de la Sociedad Espanola de Oftalmologia,
J J Pérez-Santonja, and E Campos-Mollo, and E Fuentes-Campos, and J Samper-Giménez, and J L Alió
April 2010, Ophthalmology,
Copied contents to your clipboard!